Holdings
Enavate Sciences Gp, LLC
As of Sep 30, 2026, Enavate Sciences Gp, LLC reported 8 positions worth US$280M. Largest: Zenas BioPharma, Inc., Immunome, Inc. and Braveheart Bio, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Zenas BioPharma, Inc. | 2.92M | US$78.7M | −1M | Sep 30, 2026 |
| Immunome, Inc. | 3.61M | US$77.7M | no change | Sep 30, 2026 |
| Braveheart Bio, Inc. | 3.67M | US$74.2M | new | Sep 30, 2026 |
| Sionna Therapeutics, Inc. | 2.48M | US$13M | no change | Sep 30, 2026 |
| Upstream Bio, Inc. | 2.46M | US$13M | no change | Sep 30, 2026 |
| BridgeBio Oncology Therapeutics, Inc. | 2.63M | US$10.8M | no change | Sep 30, 2026 |
| Compass Therapeutics, Inc. | 7.79M | US$8.1M | no change | Sep 30, 2026 |
| CAMP4 Therapeutics Corporation | 1.04M | US$4.21M | −384K | Sep 30, 2026 |